Novo Nordisk Stages a Two-Front Offensive: Oral Wegovy Explodes in the US While China Beckons
Shares of Novo Nordisk surged more than 4% on Friday to 39.23 euros, as investors digested a barrage…
Novo Nordisk’s Oral GLP-1 Offensive Meets a Wall Street Reality Check
Novo Nordisk faces revenue squeeze as oral Wegovy prescriptions plateau at starter doses, Eli Lilly enters the pill-based…